Top Markets
#1 Islamic Coin Islamic Coin +152.50%
#2 Bitway Bitway +42.48%
#3 Starpower Starpower +38.69%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +33.29%
#5 aelf aelf +28.49%
#6 Pons Pons +26.56%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.55%
#8 SkyAI SkyAI +19.30%
#9 Ocean Protocol Ocean Protocol +16.33%
#10 Bedrock Bedrock +15.75%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Onco-Innovations Ltd. Onco-Innovations Ltd.

Onco-Innovations Ltd.

ONCO
Kedudukan dalam Saham #29549
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on... Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Harga Saham
$0.47705898
Disegerakkan terakhir: 2026-07-15
Modal Pasaran
$20.69M
Perubahan (1 hari)
3.17%
Perubahan (1 tahun)
-65.19%
Negara
CA
Perdagangan Onco-Innovations Ltd. (ONCO)

Kategori

Healthcare
Sejarah pecahan saham untuk Onco-Innovations Ltd. (ONCO)
Saham Onco-Innovations Ltd. (simbol: ONCO) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham ONCO yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham ONCO.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR